is a developer of advanced biomedical devices that utilizes Nanoweave™, a proprietary scaffolding technology that can be tailored to address a wide range of high-value applications in the fields of tissue engineering. The Company’s patented core technology provides the means to assemble scaffolding in such a way that mimics human tissue structure and directly influence cell behavior. Using commercially available medical-grade collagen, Nanoweave’s properties assures that the resulting medical devices are naturally accepted by neighboring tissue, supporting the body’s regenerative repair and maintenance process.
In 2016 Fibralign is launching it’s first product BioBridge™ and engaging in clinical studies to evaluate its use for treating and preventing secondary lymphedema (the device is not cleared by the FDA for use in the treatment of lymphedema), as well as advancing R&D development for new applications for treating ischemia and novel delivery devices for use with stem cells and gene therapy.
Fibralign can apply its Nanoweave technology for orientating collagen fibers and custom manufacture medical devices to meet a specific application need. Contact Fibralign for more information!